Navigation Links
UCLA life scientists, colleagues differentiate microbial good and evil
Date:1/9/2014

To safely use bacteria in agriculture to help fertilize crops, it is vital to understand the difference between harmful and healthy strains. The bacterial genus Burkholderia, for example, includes dangerous disease-causing pathogens one species has even been listed as a potential bioterrorist agent but also many species that are safe and important for plant development.

Can the microbial good and evil be told apart? Yes, UCLA life scientists and an international team of researchers report Jan. 8 in the online journal PLOS ONE.

"We have shown that a certain group of Burkholderia, which have just been discovered in the last 12 years as plant-growth promoting bacteria, are not pathogenic," said the study's senior author, Ann Hirsch, a professor of molecular, cell, and developmental biology in the UCLA College of Letters and Science. "This opens up the possibility of using these particular species for promoting plant growth through the process of nitrogen fixation, particularly in areas of climate change. This will have a major impact, especially on people in the developing world in producing protein-rich crops."

Nitrogen fixation is a process by which helpful bacteria that have entered the roots of plants convert nitrogen in the atmosphere into ammonia, which helps the plants thrive. The findings of Hirsch and her colleagues indicate that several recently discovered Burkholderia species, including Burkholderia tuberum, could be used cautiously in nitrogen fixing. These species, the scientists discovered, lack those genes that make other Burkholderia species harmful agents of infection.

"Bacteria that fix atmospheric nitrogen into ammonia, such as Burkholderia, are critical for plant growth," said Hirsch, whose laboratory studies many aspects of the complex symbiosis between plants and bacteria. "We're especially interested in these recently described Burkholderia species because they are found primarily in the dry and acidic soils of the Southern Hemisphere, making them potentially important for agriculture in less productive areas."

For their study, the UCLA life scientists performed a bioinformatics analysis of four symbiotic Burkholderia species, all of which fix nitrogen and one, B. tuberum, which "nodulates legumes." They found a strong distinction between genes in these beneficial strains and in pathogenic strains. They searched for genes typically involved in infection for attaching to and invading cells or for secreting toxins. Unlike their dangerous cousins, the four symbiotic Burkholderia species did not have genes associated with the virulence systems found in the pathogenic species.

Burkholderia were first discovered as plant pathogens in 1949 by Walter Burkholder, who identified them as the agent causing onion-skin rot. Later, Burkholderia species were identified as the causative agent of the disease melioidosis, a public health threat, especially in tropical countries like Thailand and in parts of Australia. B. pseudomallei, which causes melioidosis, is classified by the Centers for Disease Control and Prevention as a potential bioterrorist agent.

Other Burkholderia belong to the Burkholderia cepacia complex, a group of related bacteria that are not true pathogens but can cause "opportunistic" or hospital-acquired infections in people with weakened immune systems or with cystic fibrosis. Although some members of the Burkholderia cepacia complex have been used to protect plants from dangerous fungal infections, their potential to cause infection has resulted in severe limits on their use in agriculture.

It wasn't until many decades after Burkholder's discovery that closely related Burkholderia species were found to enter plant roots not as pathogens but as helpful symbionts generating root nodules in which the bacteria provide nitrogen fertilizer to the plant. Bacteria that cause the formation of these nodules in legumes, such as soybeans, alfalfa and peanuts, are crucial to sustainable agricultural systems, Hirsch said.

Although the nodulating, symbiotic species of Burkholderia are related to the more dangerous species, a detailed analysis of their evolutionary relationships published earlier this year by Hirsch and her colleagues showed that the two groups have a distinct evolutionary lineage.

The harmful Burkholderia species are more resistant to antibiotics than the symbiotic and agricultural strains. In addition to the bioinformatics analysis in the current study, the team analyzed resistance to a panel of common antibiotics, and tested the potential of different Burkholderia species to cause infection in laboratory conditions.

Experiments testing the potential of the four symbiotic species to cause infection in the small nematode worm known as Caenorhabditis elegans and in human cells grown in culture verified the bioinformatics analysis, showing that the bacteria were not harmful.

"We used a variety of detailed experiments to make sure that the symbiotic species are safe to put into farmers' fields and home gardens, just like currently used nitrogen-fixing bacteria," Hirsch said. "Our goal is to have these newly discovered nitrogen-fixing bacteria be used for a more sustainable approach to agriculture in the future."


'/>"/>

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles
Source:Eurekalert

Related biology news :

1. Worlds scientists, researchers and nutrition experts convene to explore the benefits of mushrooms
2. American Chemical Society resource connects scientists, discoveries, chemistry & biology interface
3. Maintaining Earths sustainability: Scientists, engineers, educators take coordinated approach
4. Hypertension researcher encourages colleagues to expand their focus
5. U-M researcher and colleagues predict possible record-setting Gulf of Mexico dead zone
6. Virginia Tech adjunct and colleagues refute a study on racial bias report in NIH awards
7. Microbiome in gut, mouth, and skin of low birth weight infants differentiate weeks after birth
8. BUSM study shows potential of differentiated iPS cells in cell therapy without immune rejection
9. How to Differentiate Your Pharmaceutical Product in the Personalized Medicine Segment
10. Molecular spectroscopy tracks living mammalian cells in real time as they differentiate
11. New CU-Boulder-led study finds microbial clock may help determine time of death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
Breaking Biology Technology: